Prediction of Peritoneal Metastasis for Gastric Cancer Based on Radiomics
Recruiting now
Conditions studied: Gastric Cancer, Peritoneal Metastases
In brief
Peritoneal metastasis of gastric cancer is difficult to be detected in time, thus delaying treatment. Based on the conventional CT images of gastric cancer, this study plans to develop, improve and validate an intelligent analysis system based on radiomics. By extracting and combining the radiomics features related to peritoneal metastasis of gastric cancer, the intelligent analysis system could predict the risk of peritoneal metastasis, and provide personalized decision suggestions for the treatment of gastric cancer.
Key facts
- Study ID
- NCT05722275
- Run by
- Chinese Academy of Sciences
- People needed
- 400
- Starts
- 2023-01-01
- Expected to finish
- 2028-12-31
- Last updated by the study team
- 2023-02-14
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- (1) diagnosed advanced gastric cancer (≥cT3) by endoscopy-biopsy pathology, combined with CT and/or endoscopic ultrasound;
- (2) with both enhanced CT and laparoscopy;
- (3) without typical peritoneal metastasis indications in CT (diffuse omental nodules or omental cake, large amount of ascites, obvious irregular thickening with high peritoneal enhancement);
- (4) without other evidence of distant metastasis, and no stage IV features on CT.
You may not qualify if…
- (1) previous abdominal surgery;
- (2) previous abdominal malignancies or inflammatory diseases;
- (3) time intervals between CT and laparoscopy longer than 2 weeks;
- (4) CT image artifacts that undermine peritoneal lesion assessment.
Where it is running
- Peking University Cancer Hospital & Institute — Beijing, China (enrolling)
- Fujian Medical University Union Hospital — Fuzhou, China (enrolling)
- Affiliated Cancer Hospital and Institute of Guangzhou Medical University — Guangzhou, China (enrolling)
- Guangdong Provincial People's Hospital — Guangzhou, China (enrolling)
- Nanfang Hospital of Southern Medical University — Guangzhou, China (enrolling)
- Sun Yat-Sen University Cancer Hospital — Guangzhou, China (enrolling)
- Guizhou Provincial People's Hospital — Guiyang, China (enrolling)
- Yunnan Cancer Hospital — Kunming, China (enrolling)
- Shanxi Province Cancer Hospital — Taiyuan, China (enrolling)
- Henan Cancer Hospital — Zhengzhou, China (enrolling)
- The First Affiliated Hospital of Zhengzhou University — Zhengzhou, China (enrolling)
- Zhenjiang First People's Hospital — Zhenjiang, China (enrolling)
- Scientific Institute San Raffaele — Milan, Italy (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.